Blood Weekly articles from February 2004

Blood Weekly archives from February 2004

CD133-based stem-cell selection feasible with alternative donors.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- CD133-based stem-cell selection is feasible for use with alternative donors. "Positive selected hematopoietic stem cells are increasingly used for allogeneic transplantation with the CD34 antigen...

Full peripheral blood RBC chimerism needed for SCD cure.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Full peripheral blood RBC chimerism is needed for bone marrow graft-induced SCD resolution. "Bone marrow transplantation (BMT) is the only curative therapy for sickle cell disease (SCD)," scientists...

HSCT safe and effective for Taiwanese SAA patients.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Hematopoietic stem-cell transplantation is safe and effective for Taiwanese SAA patients. According to research from Taiwan, HSCT "is an accepted treatment strategy for patients with severe...

Muscle-derived stem cells may have limited hematopoietic potential.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- With standard harvesting techniques, muscle-derived stem cells have limited hematopoietic potential. According to scientists in the United States, "Recent studies have suggested a remarkable...

CMV-seropositive donors might be preferable for seropositive SCT recipients.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Cytomegalovirus (CMV)-seropositive stem-cell donors may increase the safety and efficacy of transplantation for CMV-seropositive recipients. CMV infection "has been a major cause of morbidity and...

High-level cryopreservation of mobilized PBSC feasible without programmed freezer.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Mobilized PBSCs can be cryopreserved at high cell concentrations without the use of a programmed freezer. "Cryopreservation of peripheral blood stem cells (PBSC) mobilized by chemotherapy combined...

Inorganic arsenic therapies may have toxic side effects.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Inorganic arsenic therapies may have toxic side effects. According to published research from the United States, "trivalent inorganic arsenic (arsenite, arsenic trioxide, As (III) is currently...

Lamivudine prevents rituximab-induced hepatitis B virus reactivation.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Lamivudine prevents rituximab-induced hepatitis B virus reactivation. According to researchers in Japan, "we used regimens containing rituximab in the treatment of five hepatitis B virus surface...

Hemopure regulatory status updated following FDA meeting.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Biopure Corporation (BPUR) reported that, on January 6, 2004, the company and the U.S. Food and Drug Administration (FDA) met at Biopure's request to discuss its reply to the FDA complete response...

Th1 polarization underlies hematopoietic dysfunction in AAA patients.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Th1 polarization underlies hematopoietic dysfunction in AAA patients. "Immune dysfunction, which leads to the suppression of hemopoiesis by cytokines that are secreted by activated T lymphocytes,...

Enrollment complete for phase II clinical study in non-Hodgkin lymphoma.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Favrille, Inc., has completed enrollment for its current phase II clinical trial (FavId-04) with the company's lead investigational agent, FavId. This agent is under clinical development for the...

FLAG[+ or -]Ida suitable for induction chemo in high-risk leukemia, MDS patients.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- FLAG[+ or -]Ida is safe and effective as induction chemotherapy in high-risk leukemia and MDS patients. According to recent research from England, "The combination of fludarabine (FDR), high dose...

Granulocyte colony-stimulating factor reduces complications in elderly patients.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Further research studies are needed to identify the elderly patients who will benefit most from prophylactic granulocyte colony-stimulating factor (G-CSF). "According to recent research from Italy,...

Action needed to prevent spread of vCJD via blood.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Urgent action is needed to protect the public from variant Creutzfeldt-Jakob disease (vCJD), a senior member of the Medical Research Council says. Dr. Sheila Bird argued in the British Medical...

Methemoglobin levels correlate with environmental exposures in pregnant women.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Methemoglobin levels correlate with environmental exposures in pregnant women. "The objective of this prospective study was to determine if a correlation could be established between the...

Instrument-reagent company announces fiscal second quarter results.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Immucor, Inc., (BLUD), a provider of automated instrument-reagent systems to the blood transfusion industry, reported financial results for the fiscal second quarter and 6 months ended November 30,...

Ex vivo gene therapy rectifies Niemann-Pick disease in animal models.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Ex vivo gene therapy rectifies Niemann-Pick disease in animal models. "Normal murine bone marrow cells were transduced with a retroviral vector to overexpress and release human acid sphingomyelinase...

Dried blood suitable for HIV diagnosis in the field.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Dried blood samples are suitable for diagnosis of HIV under field conditions. According to published research from Zambia, "The increasing availability of antiretroviral drugs to HIV-infected...

Perfluorocarbon-based blood substitute to undergo phase II clinical testing.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Synthetic Blood International Inc. (SYBD) announced that phase II clinical testing of Oxycyte, the company's perfluorocarbon (PFC)-based blood substitute and therapeutic oxygen carrier, is on schedule...

Erythropoietin amends therapy-induced anemia in patients with hepatitis C.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Erythropoietin amends therapy-induced anemia in patients with hepatitis C. "We are presenting 20 patients with hepatitis C, who developed anemia on interferon alpha-2b/ribavirin treatment and were...

Integrin-ligand interactions synergize in arterial injury platelet adhesion.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. According to published research from Germany, "Damage to the integrity of...

Liver cancer rates parallel the aging of thalassemic populations in Italy.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Liver cancer rates parallel the aging of thalassemic populations in Italy. According to a study from Italy, "hepatocellular carcinoma (HCC) frequently complicates hepatic cirrhosis secondary to...

Platelet-activating factor stops enzyme secretion in decidual macrophages.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Platelet-activating factor stops enzyme secretion in decidual macrophages. According to recent research from Japan, "to clarify the role of platelet-activating factor (PAF) in parturition, the...

Transduced stem cells hold the potential for correcting sickle cell disease.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Transduced stem cells hold the potential for correcting sickle cell disease. "Although sickle cell anemia was the first hereditary disease to be understood at the molecular level, there is still no...

H. pylori CagA mimicry may underlie cITP.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Molecular mimicry by the Helicobacter pylori CagA protein may underlie cITP associated with infection. H. pylori eradication "often leads to platelet recovery in patients with chronic idiopathic...

HFE gene mutations associate with fibrosis in chronic hepatitis C patients.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- HFE gene mutations associate with fibrosis in chronic hepatitis C patients. "Mild iron overload in chronic hepatitis C is associated with liver fibrosis, hepatitis C virus (HCV) genotype 1b...

Common clonal origin seen in twins with leukemia.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Study results indicate that further postnatal exposures, genetic events, or both are needed to produce clinical disease in twins. "According to a study from England, "Identical infant twins with...

Fludarabine-based regimens are effective but toxic in elderly patients with CLL.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Reducing fludarbine and using myeloid growth factors and antibiotics are necessary to maintain quality of life in elderly patients with chronic lymphocytic leukemia (CLL). According to recent...

Malignant stem cells express high levels of FGFR-3.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Leukemic stem cells express heightened levels of FGFR-3. Scientists in the Czech Republic had previously found that "expression of myeloma-associated (proto) oncogene fibroblast growth factor...

LightCycler, TaqMan tests equally suitable for pediatric MRD measurement.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- LightCycler- and TaqMan-based tests are equally suitable for measuring MRD in pediatric ALL patients. "Quantification of residual leukemic cells at early time points during therapy can reliably...

MRP3 linked to drug resistance in pediatric ALL.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- The MRP3 protein appears to contribute to drug resistance in pediatric ALL. According to a study from Germany, "The family of multidrug resistance-associated proteins (MRPs) belongs to the...

ZAP-70 expression is a prognostic factor in CLL patients.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Elevated ZAP-70 expression is a predictor of poor outcome in chronic lymphocytic leukemia (CLL) patients. B-cell CLL (B-CLL) is "a heterogenous disease with a highly variable clinical course,"...

Advanced follicular lymphoma responds to anthracycline-containing regimens.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Study shows that anthracycline-containing regimens (ACR) should be considered as the standard treatment of patients with advanced follicular lymphoma. According to published research from Italy, "In...

Diffuse large B-cell lymphoma patients should undergo aggressive treatment.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Study finds that patients with diffuse large B-cell lymphoma (DLBCL) arising in nodular lymphocyte predominant Hodgkin disease (NLPHL) have a prognosis similar to those with de novo DLBCL and should be...

Post-traumatic stress disorder can result from Hodgkin disease and NHL.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Study finds that lymphoma can lead to post-traumatic stress disorder (PTSD) and that early psychological interventions may help reduce morbidity and improve quality of life (QoL). "According to...

Role of FLIP isoforms in apoptosis elucidated.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- The pro-apoptotic activity of FLIP isoforms in MDS patients has been elucidated. "Several apoptosis-inducing systems, including Fas/Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) and...

Safety blood collection needle product line launches in U.S.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Specialized Health Products International, Inc., (SHPI) and Kendall, a business unit of Tyco Healthcare, announced the U.S. market launch of a proprietary line of safety blood collection products, based...

An international working group reports on the epidemiology of neonatal tumors.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Study concludes that certain cytogenetic anomalies appear to be specific to neonates. "Neonatal tumors occur every 12,500 to 27,500 live births and comprise 2% of childhood malignancies, but there...

Update provided on program evaluating Proleukin interleukin-2.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) announced that the company has decided to expand its program to evaluate the efficacy of Proleukin interleukin-2 (IL-2, aldesleukin) and rituximab in patients with low-grade...

Children's hospitals across the U.S. are expanding.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Sixteen-year-old lymphoma patient Heather Moore was pleasantly surprised when she saw her new room at Children's Medical Center Dallas. The walls were painted in a colorful pastel as opposed to the...

Bone marrow-derived stem cells active in pulmonary fibrosis.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Adult stem cells have long been thought to be restricted in their potential to differentiate and regenerate tissues in which they reside. A study by Sem Phan and colleagues from the University of...

Factor XIII A is essential for maintaining placental integrity.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Factor XIII A is essential for maintaining placental integrity. "To understand the molecular pathology of factor XIII (FXIII) deficiency in vivo, its A subunit (FXIIIA)-knockout (KO) mice were...

Unusual leukemia caused by rare combination of genes.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Two children who developed leukemia after receiving gene therapy for an inherited disease may have been victims of a rare combination of genes that is unlikely to happen in gene therapy for other...

Clinical compound rPSGL-Ig licensed for development and commercialization.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Thios Pharmaceuticals, Inc., announced the signing of a licensing agreement with Wyeth granting Thios exclusive worldwide rights to develop and commercialize the compound rPSGL-Ig, a recombinant form of...

Acute myeloid leukemia fusion proteins deregulate maintenance and repair genes.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Acute myeloid leukemia fusion proteins deregulate maintenance and repair genes. "Acute myelogenous leukemias (AMLs) are genetically heterogeneous and characterized by chromosomal rearrangements that...

Bax and Bak regulate size of neural stem-cell pool.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- The Bax and Bak proteins regulate the size of the neural stem-cell pool. According to scientists in the United States, "The proapoptotic Bcl-2 family members Bak and Bax play central and redundant...

Concepts of stem-cell plasticity reviewed.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Advances in the understanding of stem-cell plasticity have been reviewed. "For many years, adult hemopoietic stem cells (HSCs) have been considered 'plastic' in their proliferative and...

Hematopoietic progenitor subset expresses neural genes.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Some hematopoietic progenitor cells express neural genes. "Bone marrow, or cells selected from bone marrow, were reported recently to give rise to cells with a neural phenotype after in vitro...

Japanese university produces first human embryo stem cells for domestic research.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- A Japanese university has produced the country's first human embryonic stem cells, a development that could spur biotechnology research there if the government approves them for use. Norio...

Pathological links between PNH and aplastic anemia reviewed.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- The pathological links between paroxysmal nocturnal hemoglobinuria and aplastic anemia have been reviewed. "The clinical association between paroxysmal nocturnal hemoglobinuria (PNH) and aplastic...

Impaired naive T-cell survival underlies post-SCT immunodeficiency.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Impaired survival of naive T cells - rather than poor thymic function - underlies the post-transplant immune dysfunction in stem-cell graft recipients. According to a study from Canada, "Allogeneic...

The cleaning solvent HCFC-141b produces genotoxic effects in rodents.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- The cleaning solvent HCFC-141b produces genotoxic effects in rodents. According to a study from South Korea, "to investigate the genotoxic effect of 1,1-dichloro-1-fluoroethane (HCFC-141b), which...

PBMC-PCR can facilitate tuberculous lymphadenitis diagnosis.
February 5, 2004... 2004 FEB 5 - (NewsRx.com & NewsRx.net) -- PBMC-PCR testing can facilitate the diagnosis of tuberculous lymphadenitis. "Providing prompt and precise laboratory confirmation of a clinical diagnosis of tuberculous lymphadenitis is difficult...

Risedronate prevents bone loss in allo-SCT survivors.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Risedronate treatment improves bone density in long-term allo-SCT survivors. In a recent study, scientists in Italy "evaluated the effect of risedronate, an aminobisphosphonate, on bone mass and...

Better treatment of porcine RBCs needed before human transfusion is feasible.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Better treatment of porcine blood cells is required for transfusion of such cells into humans to be feasible. According to recent research from Switzerland, "There is a shortage of human blood for...

Campath-1H can improve outcome for ALL patients with post-SCT relapse.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Campath-1H may improve the chance of survival for ALL patients who suffer post-SCT relapse. "Despite aggressive approaches, including second transplant, donor lymphocyte infusion and several new...

Filgrastim stem-cell mobilization safe and effective during imatinib treatment.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Filgrastim-based stem-cell mobilization is safe and effective during imatinib treatment in CML patients. "Therapy with imatinib mesylate is limited by cellular resistance in chronic myeloid...

CD41 expression defines hematopoiesis onset in murine embryo.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- The acquisition of CD41 expression defines the onset of hematopoiesis in the murine embryo. According to recent research from the United States, "The platelet glycoprotein IIb (alpha(IIb); CD41)...

IL-21 triggers rapid maturation of natural killer cell precursors.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- The cytokine interleukin (IL)-21 triggers the rapid maturation of natural killer (NK) precursor cells. According to recent research from Italy, "The NK cell maturation from...

Man accused of falsely telling woman he gave her AIDS.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- An Erie, Pennsylvania, man has been charged with terroristic threats for falsely telling a woman that he gave her AIDS, police said. Richard Forness, Jr., 22, of Erie, was also charged with...

Bulgarian medics trial postponed.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- A court in Tripoli, Libya, on January 12, 2004, postponed the trial of six Bulgarian medics accused of intentionally infecting more than 400 children with the AIDS virus, court officials said. The...

Prosecutors proceed cautiously with stabbing victim who refused transfusion.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- When Carol Ferenz stood by her religious principles, it may have cost her life. Ferenz, a Jehovah's Witness, turned down a blood transfusion after she was stabbed multiple times in her Greenwich,...

Once-weekly Dalbavancin shows superiority for bloodstream infections in study.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Vicuron Pharmaceuticals Inc. announced results of a phase II clinical trial demonstrating that dalbavancin showed superior efficacy to vancomycin, the current standard of care for the treatment of...

Bone graft clinical trial initiated at lead U.S. site.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that its U.S. clinical trial of the company's bone generation tissue repair cell (TRC) stem cell product has been initiated at its lead clinical trial site...

Further studies of transplanted composite bone grafts-implants are needed.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Preliminary results of an animal study suggest that immediate transplantation of titanium implants with the surrounding bone into recipient osseous sites in the jaw cannot predictably yield...

Researchers discover secret for recalling stem cells.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- While "location, location, location" has long been the mantra in real estate, it may soon become the buzzword of stem cell scientists everywhere. Weill Cornell researchers have discovered that bone...

Exposure to high levels of trichloroethylene may be increase risk of NHL.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Results of several studies indicate that occupational exposure to trichloroethylene at past higher levels may be associated with elevated risk for non-Hodgkin lymphoma. "Trichloroethylene is an...

High-dose TMC with stem-cell support shows promise in multiple myeloma.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- High-dose TMC chemotherapy with autologous stem-cell support shows promise as treatment for multiple myeloma. Oncologists in the United States conducted a study "to assess the toxicity and...

GATA4 triggers cardiomyocyte development in Xenopus explants.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- GATA4 triggers cardiomyocyte development in Xenopus explants. "The earliest step in heart formation in vertebrates occurs during gastrulation, when cardiac tissue is specified," scientists in...

Gene causing tumors by "double-whammy" mechanism also reveals the key to a cure.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Scientists at the Babraham Institute have discovered that a tiny change in a protein involved in cell survival is responsible for abnormal cell activity in the early stages of cancer. The protein,...

Marrow fibrosis indicates therapy failure in chronic myeloid leukemia.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Study finds that marrow fibrosis (MF) is an independent poor prognostic complication of chronic myeloid leukemia (CML), indicating therapy failure. "Marrow fibrosis has rarely been considered in...

Agreement signed with Atria Genetics for tissue typing tests.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced a worldwide distribution agreement with South San Francisco, California-based Atria Genetics, Inc., doing business as Forensic Analytical/Molecular Genetics, for a...

Systems biology company to develop hematology model for Johnson & Johnson.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Entelos, Inc., announced that they will develop a hematology model for Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD). In addition, Entelos will conduct an in silico research...

CAM treatments could hinder cancer treatment.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Cancer patients who use herbal remedies and health supplements during conventional treatment may risk dangerous side effects, according to a new report. Garlic, cod liver oil and St. John's wort...

Singapore to ask mothers to donate cord blood.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Singapore's government health service said on January 20, 2004, that 40% of new mothers in the city-state will soon be asked to donate their umbilical cord blood to help patients with leukemia, severe...

Researchers propose guidelines for managing primary cutaneous T-cell lymphomas.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Evidence-based guidelines for cutaneous T-cell lymphoma are developed. "These guidelines for the management of cutaneous T-cell lymphoma have been prepared for dermatologists on behalf of the...

Study shows DVT preventative treatment not implemented in high-risk patients.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Researchers at Brigham and Women's Hospital (BWH) have found that the majority of patients at risk for deep-vein thrombosis (DVT) and its serious accompaniment, pulmonary embolism (PE), are not...

Lack of matrix metalloproteinase-9 ensures faulty bone formation.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Lack of matrix metalloproteinase-9 ensures faulty bone formation. "The regeneration of adult skeletal tissues requires the timely recruitment of skeletal progenitor cells to an injury site, the...

Blood safety products company announces $6.6 million private placement.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- V.I. Technologies, Inc., (VITX) announced that it had entered into agreements to sell approximately 7,332,222 shares of its common stock to institutional investors at a negotiated price of $0.90 per...

Gene-disabling technique simplified by medical school team.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Sometimes the first step to learning a gene's role is to disable it and see what happens. Now researchers at the Stanford University School of Medicine have devised a new way of halting gene...

Asians could benefit from education about genetic research.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Public education programs to promote participation in genetic research should stress its benefits and address people's fears and concerns. "Studies on the public's willingness to donate blood...

Serum preferable to plasma for KSHV load testing.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Serum is preferable to plasma for KSHV load testing in KS patients. "Human herpesvirus 8 (HHV-8) (or Kaposi sarcoma [KS]-associated herpesvirus) is associated with all forms of KS," and "HHV-8 DNA...

Presidential candidate Clark would lift stem cell restrictions.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- Wesley Clark would lift federal funding restrictions President Bush put on stem cell research in 2001 if elected president, he told The Associated Press in an interview January 16, 2004. The...

NIH grant awarded to study the use of adipose-derived regenerative cells.
February 12, 2004... 2004 FEB 12 - (NewsRx.com & NewsRx.net) -- MacroPore Biosurgery, Inc., (XMP) announced that it has been awarded a fast track phase I/II small business innovation research (SBIR) grant from the U.S. National Institutes of Health to study the...